Published on 16 Jan 2023 on Simply Wall St. via Yahoo Finance
Lipocine (NASDAQ:LPCN) has had a great run on the share market with its stock up by a significant 31% over the last month. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Particularly, we will be paying attention to Lipocine's ROE today.
ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.
Check out our latest analysis for Lipocine